Attila Tamas-Szora

Attila Tamas-Szora

Auto-generated profile, based on publicly available information

Attila Tamas-Szora

Department of Radiology, Clinical Municipal Hospital, 400139 Cluj-Napoca, Romania

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2020 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
CMClaudia-Gabriela Moldovanu
Claudia-Gabriela Moldovanu
B(Bianca Boca (Petresc)
Bianca Boca (Petresc)
ALAndrei Lebovici
Andrei Lebovici
ATAttila Tamas-Szora
Attila Tamas-Szora
DFDiana Sorina Feier
Diana Sorina Feier
MBMircea Marian Buruian
Mircea Marian Buruian
Nuclear grade is important for treatment selection and prognosis in patients with clear cell renal cell carcinoma (ccRCC). This study aimed to determine the ability of preoperative four-phase multiphasic multidetector computed tomography (MDCT)-based radiomics features to predict the WHO/ISUP nuclear grade. In all 102 patients with histologically confirmed ccRCC, the training set (n = 62) and validation set (n = 40) were randomly assigned. In both datasets, patients were categorized according to the WHO/ISUP grading system into low-grade ccRCC (grades 1 and 2) and high-grade ccRCC (grades 3 and 4). The feature selection process consisted of three steps, including least absolute shrinkage and selection operator (LASSO) regression analysis, and the radiomics scores were developed using 48 radiomics features (10 in the unenhanced phase, 17 in the corticomedullary (CM) phase, 14 in the nephrographic (NP) phase, and 7 in the excretory phase). The radiomics score (Rad-Score) derived from the CM phase achieved the best predictive ability, with a sensitivity, specificity, and an area under the curve (AUC) of 90.91%, 95.00%, and 0.97 in the training set. In the validation set, the Rad-Score derived from the NP phase achieved the best predictive ability, with a sensitivity, specificity, and an AUC of 72.73%, 85.30%, and 0.84. We constructed a complex model, adding the radiomics score for each of the phases to the clinicoradiological characteristics, and found significantly better performance in the discrimination of the nuclear grades of ccRCCs in all MDCT phases. The highest AUC of 0.99 (95% CI, 0.92–1.00, p < 0.0001) was demonstrated for the CM phase. Our results showed that the MDCT radiomics features may play a role as potential imaging biomarkers to preoperatively predict the WHO/ISUP grade of ccRCCs.

28 October 2020 in Medicina
Verified
Journal Article
Open access
PDF file
CMClaudia-Gabriela Moldovanu
Claudia-Gabriela Moldovanu
B(Bianca Boca (Petresc)
Bianca Boca (Petresc)
ALAndrei Lebovici
Andrei Lebovici
ATAttila Tamas-Szora
Attila Tamas-Szora
MSMihai Domnutiu Suciu
Mihai Domnutiu Suciu
MBMircea Marian Buruian
Mircea Marian Buruian
Background and objectives: The use of non-invasive techniques to predict the histological type of renal masses can avoid a renal mass biopsy, thus being of great clinical interest. The aim of our study was to assess if quantitative multiphasic multidetector computed tomography (MDCT) enhancement patterns of renal masses (malignant and benign) may be useful to enable lesion differentiation by their enhancement characteristics. Materials and Methods: A total of 154 renal tumors were retrospectively analyzed with a four-phase MDCT protocol. We studied attenuation values using the values within the most avidly enhancing portion of the tumor (2D analysis) and within the whole tumor volume (3D analysis). A region of interest (ROI) was also placed in the adjacent uninvolved renal cortex to calculate the relative tumor enhancement ratio. Results: Significant differences were noted in enhancement and de-enhancement (diminution of attenuation measurements between the postcontrast phases) values by histology. The highest areas under the receiver operating characteristic curves (AUCs) of 0.976 (95% CI: 0.924–0.995) and 0.827 (95% CI: 0.752–0.887), respectively, were demonstrated between clear cell renal cell carcinoma (ccRCC) and papillary RCC (pRCC)/oncocytoma. The 3D analysis allowed the differentiation of ccRCC from chromophobe RCC (chrRCC) with a AUC of 0.643 (95% CI: 0.555–0.724). Wash-out values proved useful only for discrimination between ccRCC and oncocytoma (43.34 vs 64.10, p < 0.001). However, the relative tumor enhancement ratio (corticomedullary (CM) and nephrographic phases) proved useful for discrimination between ccRCC, pRCC, and chrRCC, with the values from the CM phase having higher AUCs of 0.973 (95% CI: 0.929–0.993) and 0.799 (95% CI: 0.721–0.864), respectively. Conclusions: Our observations point out that imaging features may contribute to providing prognostic information helpful in the management strategy of renal masses.

1 June 2012
Verified
Journal Article
Closed access
RBRadu Ion Badea
Radu Ion Badea
NHNadim Al Hajjar
Nadim Al Hajjar
VAVasile Andreica
Vasile Andreica
BPBogdan Procopeţ
Bogdan Procopeţ
Cosmin CaraianiCosmin Caraiani
Cosmin Caraiani
ATAttila Tamas-Szora
Attila Tamas-Szora

17 February 2019 in Medical Ultrasonography
Verified
Journal Article
Closed access
PDF file
IAIulia Andras
Iulia Andras
DCDana Crisan
Dana Crisan
ECEmanuel Cata
Emanuel Cata
ATAttila Tamas-Szora
Attila Tamas-Szora
Cosmin CaraianiCosmin Caraiani
Cosmin Caraiani
NCNicolae Crisan
Nicolae Crisan
Aims: To present our initial experience and results of MRI-TRUS fusion guided prostate biopsy and assess the role of contralateral lobe systematic biopsy.Material and method: A number of 119 patients with clinical or biochemical suspicion for prostate cancer (PCa) were included. All patients harbored at least one PIRADS score ≥ 3 lesion and underwent MRI-TRUS fusion guided biopsy, as well as a concurrent systematic biopsy. The biopsy was performed by the same operator, using a rigidregistration software system.Results: The mean age of the patients was 62.2 years. The mean pre-biopsy PSA was 9.15 ng/dl. The diagnosis rate of MRI-TRUS fusion guided biopsy was 47% for overall PCa and 29.4% for clinically significant (cs) PCa. A higher PIRADS score was significantly associated with the presence of overall and csPCa. MRI-TRUS fusion guided biopsy had a higher percentage of positive biopsy cores (51% vs 29%), higher likelihood of csPCa (OR 5.36, p=0.008) and upgrading (14.8%) in comparison with systematic biopsy but missed 6.7% csPCa. The contralateral lobe systematic biopsy could have been avoided without losing the PCa diagnosis all patients with PIRADS score 5, both in initial and repeat biopsy setting. Anterior and transitional lesions were more likely to be diagnosed only by targeted cores.Conclusion: MRI-TRUS guided prostate biopsy improves the detection of PCa, but systematic biopsy is still essential. In selected cases (PIRADS 5), contralateral lobe systematic biopsy can safely be avoided. Pre-biopsy mpMRI might reduce the number of biopsy sessions in patients with anterior and transitional lesions.

1 July 2015
Verified
Journal Article
Closed access
ATAttila Tamas-Szora
Attila Tamas-Szora
MSMihai Adrian Socaciu
Mihai Adrian Socaciu
NCNicolae Crișan
Nicolae Crișan
FDFlorentin Dobrotă
Florentin Dobrotă
PPPaul Prunduș
Paul Prunduș
RBRadu Ion Badea
Radu Ion Badea

22 July 2020
Verified
Book Chapter
Open access
PDF file
LCLidia Ciobanu
Lidia Ciobanu
ASAttila Tamas Szora
Attila Tamas Szora
ABAlexandru Florin Badea
Alexandru Florin Badea
MSMihai Domnutiu Suciu
Mihai Domnutiu Suciu
RBRadu Ion Badea
Radu Ion Badea
Nowadays, kidney tumor diagnosis benefits from large and highly accurate imagistic methods. A new imagistic method is contrast-enhanced ultrasound (CEUS) that accurately depicts the circulatory pattern of tumors. In kidney pathology, any mass or even capsular deformation depicted by B mode ultrasound represents an indication for CEUS. The kidney is completely and uniformly vascularized. In cystic tumors, there is a lack of contrast loading. In “impure” cystic masses (Bosnian 3 and 4), CEUS reveals vascularized septa and walls. In malignant tumors, accelerated and heterogeneous loading of contrast agent is observed in arterial phase followed by early, inhomogeneous washout of the contrast agent compared to normal renal parenchyma. In the abscesses, the appearance is the early loading of the walls associated with moderate hyperemia of the normal circulatory bed. This chapter details the CEUS in kidney tumor pathology, emphasizing the accurate information for the circulatory pattern of renal masses. It requires correlations with clinical data and information provided by other imaging explorations to make a final diagnosis.